
Emancro is a robotics company founded in May 2022, aiming to empower mankind through robotics. They are developing the world's first "all in one, one-for-all robot," initially focused on automating hospital pharmacy workflows and addressing labor shortages. Their flagship product, EASO 2.0, is an AI-powered, general-purpose robotic system designed to automate tasks like restocking medication cabinets and anesthesia stations, managing inventory, and tracking expiration dates. Emancro's robots integrate seamlessly with existing hospital infrastructure and are designed to reduce waste and burden on healthcare staff. The company's vision is to expand the robot's capabilities to other hospital departments such as sterile processing, dietary, and laundry.

Emancro is a robotics company founded in May 2022, aiming to empower mankind through robotics. They are developing the world's first "all in one, one-for-all robot," initially focused on automating hospital pharmacy workflows and addressing labor shortages. Their flagship product, EASO 2.0, is an AI-powered, general-purpose robotic system designed to automate tasks like restocking medication cabinets and anesthesia stations, managing inventory, and tracking expiration dates. Emancro's robots integrate seamlessly with existing hospital infrastructure and are designed to reduce waste and burden on healthcare staff. The company's vision is to expand the robot's capabilities to other hospital departments such as sterile processing, dietary, and laundry.
Headquarters: Berkeley, California
Founded: 2022
Product: EASO — AI-powered general-purpose hospital logistics robot
Initial focus: Automating hospital pharmacy workflows (medication cabinet restocking, tray assembly)
Seed raised: Seed round announced Sep 28, 2023
Hospital logistics automation (pharmacy workflows, tray assembly, inventory management).
2022
Robotics; Healthcare / Hospital logistics
Seed round announced Sep 28, 2023; Crunchbase lists AIX Ventures and Outset Capital as investors.
“AIX Ventures (lead); Outset Capital”